Literature DB >> 1658620

A novel protein factor is required for use of distal alternative 5' splice sites in vitro.

J E Harper1, J L Manley.   

Abstract

Adenovirus E1A pre-mRNA was used as a model to examine alternative 5' splice site selection during in vitro splicing reactions. Strong preference for the downstream 13S 5' splice site over the upstream 12S or 9S 5' splice sites was observed. However, the 12S 5' splice site was used efficiently when a mutant pre-mRNA lacking the 13S 5' splice site was processed, and 12S splicing from this substrate was not reduced by 13S splicing from a separate pre-mRNA, demonstrating that 13S splicing reduced 12S 5' splice site selection through a bona fide cis-competition. DEAE-cellulose chromatography of nuclear extract yielded two fractions with different splicing activities. The bound fraction contained all components required for efficient splicing of simple substrates but was unable to utilize alternative 5' splice sites. In contrast, the flow-through fraction, which by itself was inactive, contained an activity required for alternative splicing and was shown to stimulate 12S and 9S splicing, while reducing 13S splicing, when added to reactions carried out by the bound fraction. Furthermore, the activity, which we have called distal splicing factor (DSF), enhanced utilization of an upstream 5' splice site on a simian virus 40 early pre-mRNA, suggesting that the factor acts in a position-dependent, substrate-independent fashion. Several lines of evidence are presented suggesting that DSF is a non-small nuclear ribonucleoprotein protein. Finally, we describe a functional interaction between DSF and ASF, a protein that enhances use of downstream 5' splice sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658620      PMCID: PMC361750          DOI: 10.1128/mcb.11.12.5945-5953.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Alternative splicing of E1A transcripts of adenovirus requires appropriate ionic conditions in vitro.

Authors:  P Schmitt; R Gattoni; P Keohavong; J Stévenin
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

2.  The role of nucleotide sequences in splice site selection in eukaryotic pre-messenger RNA.

Authors:  L P Eperon; J P Estibeiro; I C Eperon
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

Review 3.  Pre-mRNA splicing.

Authors:  M R Green
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

4.  Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products.

Authors:  B Zerler; R J Roberts; M B Mathews; E Moran
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 5.  On/off regulation of gene expression at the level of splicing.

Authors:  P M Bingham; T B Chou; I Mims; Z Zachar
Journal:  Trends Genet       Date:  1988-05       Impact factor: 11.639

6.  Multiple cis-acting sequence elements are required for efficient splicing of simian virus 40 small-t antigen pre-mRNA.

Authors:  X Y Fu; J D Colgan; J L Manley
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

Review 7.  Sex in flies: the splice of life.

Authors:  B S Baker
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

8.  Short donor site sequences inserted within the intron of beta-globin pre-mRNA serve for splicing in vitro.

Authors:  A Mayeda; Y Ohshima
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

9.  The sex determination locus transformer-2 of Drosophila encodes a polypeptide with similarity to RNA binding proteins.

Authors:  T J Goralski; J E Edström; B S Baker
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

10.  Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins.

Authors:  C Stephens; E Harlow
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  25 in total

Review 1.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

2.  Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.

Authors:  M Molin; G Akusjärvi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus.

Authors:  H A Brady; A Scaria; W S Wold
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Purification of splicing factor SF1, a heat-stable protein that functions in the assembly of a presplicing complex.

Authors:  A Krämer
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

5.  General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection.

Authors:  X D Fu; A Mayeda; T Maniatis; A R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  Multiple activities of the human splicing factor ASF.

Authors:  J E Harper; J L Manley
Journal:  Gene Expr       Date:  1992

7.  Intronic sequence with both negative and positive effects on the regulation of alternative transcripts of the chicken beta tropomyosin transcripts.

Authors:  L Balvay; D Libri; M Gallego; M Y Fiszman
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

8.  Cooperation of pre-mRNA sequence elements in splice site selection.

Authors:  Z Dominski; R Kole
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

9.  Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243- and 289-amino-acid proteins.

Authors:  Yongping Yang; Colin McKerlie; Steven H Borenstein; Zhan Lu; Marco Schito; John W Chamberlain; Manuel Buchwald
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Splice site selection in polyomavirus late pre-mRNA processing.

Authors:  D B Batt; L M Rapp; G G Carmichael
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.